Chronic conditions, such as rheumatoid arthritis, usually require lifelong injections. Patients skip doses due to needle phobia, injection-associated infection, and pain, which encourages the development of new delivery strategies that combine efficacy with minimal side effects in order to a
According to a report published in eLife, a new antimalarial medicine is being released at a dose that is too low to be effective for all people who require it.
New Orleans [US], October 23 (ANI): A research of over 38,000 people found that commonly used cholesterol-lowering statins may decrease the risk of mortality and the severity of COVID-19 disease.